Today: 11 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Strategy Inc (MSTR) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 as Bitcoin Buys, Index Risk, and Holiday Trading Collide

Strategy Inc (MSTR) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 as Bitcoin Buys, Index Risk, and Holiday Trading Collide

Strategy Inc.—the company formerly known as MicroStrategy—heads into the Christmas-shortened trading week with investors focused less on its legacy software business and more on three immediate drivers: bitcoin price direction, index-provider scrutiny, and the company’s ongoing capital-raising machine that funds more BTC purchases. Yahoo Finance+2SEC+2
Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

As of Sunday, December 21, 2025, Rocket Lab Corporation stock is heading into a holiday-shortened trading week after a stunning two-day surge that pushed shares to a record close of $70.52 on Friday, December 19. The rally has been fueled by a major U.S. national-security satellite award—Rocket Lab’s largest contract to date—alongside fresh launch momentum that capped off a milestone year for its Electron rocket. StockAnalysis+2MarketWatch+2
Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Warner Bros. Discovery, Inc. Series A stock heads into a holiday-shortened week with the kind of headline-driven volatility that rarely shows up in “normal” media earnings models. The reason is simple: WBD is now trading less like a traditional entertainment company and more like a live deal—anchored between two competing paths to a potential takeover.
ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow, Inc. heads into the week of December 22–26, 2025 with momentum in its product narrative—but also with headline risk that has recently dominated the stock. The company has closed its largest acquisition to date, announced a security-focused buyout of identity specialist Veza, and completed a 5-for-1 stock split—all while markets digest reports that ServiceNow is in advanced talks to buy cybersecurity firm Armis for up to $7 billion. Reuters+3ServiceNow Newsroom+3ServiceNow Newsroom+3
Mastercard Stock (NYSE: MA) Week Ahead: Buyback Tailwinds, Legal Headlines, and Holiday Data Set the Tone for Dec. 22–26, 2025

Mastercard Stock (NYSE: MA) Week Ahead: Buyback Tailwinds, Legal Headlines, and Holiday Data Set the Tone for Dec. 22–26, 2025

Mastercard Incorporated heads into the week of December 22–26, 2025 with a familiar mix of year-end catalysts: a holiday-shortened trading calendar, fresh legal and regulatory headlines across the payments ecosystem, and renewed focus on shareholder returns after Mastercard’s dividend hike and new buyback authorization earlier this month. NASDAQ Trader+2Reuters+2
21 December 2025
AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

As of Sunday, December 21, 2025, AbbVie Inc. heads into a holiday-shortened trading week with shares hovering near the mid-$220s, after a high-volume rebound into Friday’s close. The setup for the week ahead is defined by two competing forces: strong underlying fundamentals and a renewed policy overhang as Washington accelerates its latest push to align U.S. drug prices with lower international benchmarks.
QUALCOMM Incorporated Stock (QCOM) Week Ahead: Alphawave Deal Closes Early, AI Data Center Push, and Holiday-Week Trading Setup (Dec 22–26, 2025)

QUALCOMM Incorporated Stock (QCOM) Week Ahead: Alphawave Deal Closes Early, AI Data Center Push, and Holiday-Week Trading Setup (Dec 22–26, 2025)

QUALCOMM Incorporated heads into Christmas week with investors balancing two big narratives: a fresh, strategically important acquisition in data-center connectivity—and ongoing questions about the long-term shape of its handset business as Apple and broader smartphone demand evolve. Add a holiday-shortened trading week, and the next few sessions could amplify both good news and bad. Qualcomm Investor Relations+2NYSE+2
21 December 2025
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen Inc. heads into the Christmas-shortened trading week with a fresh wave of policy headlines, a newly expanded FDA label win in rare disease, and a market still laser-focused on what comes next for its obesity pipeline. Shares last traded around $327.38, following a session that ranged roughly between $323 and $331—levels that now matter even more in holiday-thinned liquidity.
Real Estate Stocks Week Ahead (Dec 22–26, 2025): REITs and Homebuilders Face Fed-Pause Signals, Mortgage-Rate Relief, and Holiday Liquidity

Real Estate Stocks Week Ahead (Dec 22–26, 2025): REITs and Homebuilders Face Fed-Pause Signals, Mortgage-Rate Relief, and Holiday Liquidity

As of Sunday, December 21, 2025, real estate stocks are heading into a holiday-shortened trading week with an unusually dense mix of cross-currents: easing mortgage rates, a Federal Reserve that just cut rates again but is now signaling patience, and thin year-end liquidity that can exaggerate daily moves. Reuters+2Freddie Mac+2
21 December 2025
Financial Services Stocks Week Ahead: Banks, Insurers, Brokers and Fintech Brace for GDP, Consumer Confidence and Holiday-Thin Trading (Dec. 22–26, 2025)

Financial Services Stocks Week Ahead: Banks, Insurers, Brokers and Fintech Brace for GDP, Consumer Confidence and Holiday-Thin Trading (Dec. 22–26, 2025)

Financial services stocks are heading into a holiday-shortened trading week with two forces pulling in opposite directions: a strong year-end backdrop for banks and brokers, and an unusually concentrated calendar of “catch-up” U.S. economic data that could jolt interest-rate expectations at precisely the time liquidity is likely to be thin.
21 December 2025
Industrials Stocks Outlook: Top News, Key Catalysts, and 2026 Forecasts (December 21, 2025)

Industrials Stocks Outlook: Top News, Key Catalysts, and 2026 Forecasts (December 21, 2025)

Industrials stocks are heading into the final trading stretch of 2025 at the center of a market that’s simultaneously celebrating a strong year and debating what comes next. The “Santa rally” window is about to open, but investors are balancing optimism with two recurring themes: unease about the return on massive AI-related spending and uncertainty over the Federal Reserve’s next move in 2026. Reuters+1
Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Sunday, December 21, 2025 — With U.S. markets heading into a holiday-shortened final trading stretch, healthcare stocks are back in focus as investors weigh a year-end “Santa rally” against a fast-moving policy backdrop that is unusually direct for the sector: drugmakers cutting prices through White House deals, insurers staring down a subsidy cliff tied to the Affordable Care Act, and a new wave of biotech dealmaking and capital-markets activity that is reopening risk appetite. Reuters+4Reuters+4The Washington Post+4
21 December 2025
1 707 708 709 710 711 880

Stock Market Today

  • Sensex Up 827 Points Led by Reliance, Banks; Nifty Gains 1%
    July 10, 2026, 9:10 PM EDT. The Sensex rose 827 points to finish at 77,569, marking its second straight day of gains. Reliance Industries, ICICI Bank, and HDFC Bank led the index higher. Softer crude prices and interest in IT helped lift stocks. The Nifty also added 1% as traders tracked firm global signals.
Go toTop